Two companies ask FDA to clarify technical aspects of a draft guidance on the development of transdermal and topical delivery systems.
FDA warns Italys Silfradent about QS and MDR violations in its manufacturing of the Surgybone medical device.
KemPharm files a 505(b)(2) for serdexmethylphenidate, indicated for treating attention deficit hyperactivity disorder.
FDA and the Centers for Disease Control and Prevention take action to make more respirators available to health care personnel because of the coronavi...
FDA warns about the SweynTooth family of cybersecurity vulnerabilities.
FDA releases its latest batch of Warning Letters that includes Acino Products, Chemland, Jiangsu JDC Medical Devices and Silfradent.
FDA warns CPAPNEA about multiple violations in its manufacturing of Optipillows.
Public Citizen calls on FDA and drug industry trade associations to publicly identify all drugs that are in shortage due to the Covid-19 epidemic.